{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:14:11Z","timestamp":1788495251752,"version":"build-2803163510"},"reference-count":36,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2024,10,22]]},"DOI":"10.2967\/jnumed.124.268751","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T16:00:17Z","timestamp":1731600017000},"page":"jnumed.124.268751","source":"Crossref","is-referenced-by-count":12,"title":["Immuno-PET\/CT Imaging of Trop2 with [<sup>18<\/sup>F]AlF-RESCA-T4 Differentiates Lung Cancer from Inflammation"],"prefix":"10.2967","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxian","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongda","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Gelardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"2024111408000982000_jnumed.124.268751v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028485"},{"key":"2024111408000982000_jnumed.124.268751v1.2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1961"},{"key":"2024111408000982000_jnumed.124.268751v1.3","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2008.060590"},{"key":"2024111408000982000_jnumed.124.268751v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604677"},{"key":"2024111408000982000_jnumed.124.268751v1.5","doi-asserted-by":"crossref","first-page":"102572","DOI":"10.1016\/j.ctrv.2023.102572","article-title":"TROP-2 directed antibody-drug conjugates (ADCs): the revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC)","volume":"118","author":"Parisi","year":"2023","journal-title":"Cancer Treat Rev."},{"key":"2024111408000982000_jnumed.124.268751v1.6","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1545"},{"key":"2024111408000982000_jnumed.124.268751v1.7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1507"},{"key":"2024111408000982000_jnumed.124.268751v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/nature12625"},{"key":"2024111408000982000_jnumed.124.268751v1.9","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.2967\/jnumed.116.186940","article-title":"Theranostics using antibodies and antibody-related therapeutics","volume":"58(suppl 2)","author":"Moek","year":"2017","journal-title":"J Nucl Med."},{"key":"2024111408000982000_jnumed.124.268751v1.10","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.9b00738"},{"key":"2024111408000982000_jnumed.124.268751v1.11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00259-021-05563-1","article-title":"ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer","volume":"49","author":"Chen","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024111408000982000_jnumed.124.268751v1.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00190.x"},{"key":"2024111408000982000_jnumed.124.268751v1.13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1146\/annurev-immunol-042617-053327","article-title":"Exploiting nanobodies\u2019 singular traits","volume":"36","author":"Ingram","year":"2018","journal-title":"Annu Rev Immunol."},{"key":"2024111408000982000_jnumed.124.268751v1.14","doi-asserted-by":"crossref","first-page":"e2250024","DOI":"10.1002\/eji.202250024","article-title":"A few good reasons to use nanobodies for cancer treatment","volume":"53","author":"Jumapili","year":"2023","journal-title":"Eur J Immunol."},{"key":"2024111408000982000_jnumed.124.268751v1.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.199901"},{"key":"2024111408000982000_jnumed.124.268751v1.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.263907"},{"key":"2024111408000982000_jnumed.124.268751v1.17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00259-023-06454-3","article-title":"ImmunoPET imaging of Trop2 expression in solid tumors with nanobody tracers","volume":"51","author":"Huang","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024111408000982000_jnumed.124.268751v1.18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/s44321-024-00059-5","article-title":"ImmunoPET imaging of Trop2 in patients with solid tumours","volume":"16","author":"Huang","year":"2024","journal-title":"EMBO Mol Med."},{"key":"2024111408000982000_jnumed.124.268751v1.19","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1158\/1078-0432.CCR-22-1305","article-title":"Expression and therapeutic targeting of TROP-2 in treatment-resistant prostate cancer","volume":"29","author":"Sperger","year":"2023","journal-title":"Clin Cancer Res."},{"key":"2024111408000982000_jnumed.124.268751v1.20","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1021\/acs.bioconjchem.6b00561","article-title":"Click chemistry and radiochemistry: the first 10 years","volume":"27","author":"Meyer","year":"2016","journal-title":"Bioconjug Chem."},{"key":"2024111408000982000_jnumed.124.268751v1.21","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1021\/acs.bioconjchem.3c00286","article-title":"Click chemistry and radiochemistry: an update","volume":"34","author":"Bauer","year":"2023","journal-title":"Bioconjug Chem."},{"key":"2024111408000982000_jnumed.124.268751v1.22","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1021\/acs.molpharmaceut.1c00733","article-title":"Annotating CD38 expression in multiple myeloma with [18F]F-Nb1053","volume":"19","author":"Wei","year":"2022","journal-title":"Mol Pharm."},{"key":"2024111408000982000_jnumed.124.268751v1.23","doi-asserted-by":"crossref","first-page":"115634","DOI":"10.1016\/j.bmc.2020.115634","article-title":"Labeling a TCO-functionalized single domain antibody fragment with 18F via inverse electron demand Diels Alder cycloaddition using a fluoronicotinyl moiety-bearing tetrazine derivative","volume":"28","author":"Zhou","year":"2020","journal-title":"Bioorg Med Chem."},{"key":"2024111408000982000_jnumed.124.268751v1.24","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1038\/s41596-018-0040-7","article-title":"Direct fluorine-18 labeling of heat-sensitive biomolecules for positron emission tomography imaging using the Al18F-RESCA method","volume":"13","author":"Cleeren","year":"2018","journal-title":"Nat Protoc."},{"key":"2024111408000982000_jnumed.124.268751v1.25","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1007\/s00259-024-06672-3","article-title":"ImmunoPET\/CT imaging of clear cell renal cell carcinoma with [18F]RCCB6: a first-in-human study","volume":"51","author":"Wu","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024111408000982000_jnumed.124.268751v1.26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00259-022-05967-7","article-title":"High in-vivo stability in preclinical and first-in-human experiments with [18F]AlF-RESCA-MIRC213: a 18F-labeled nanobody as PET radiotracer for diagnosis of HER2-positive cancers","volume":"50","author":"Qin","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024111408000982000_jnumed.124.268751v1.27","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1007\/s00259-023-06232-1","article-title":"Comparison of renal clearance of [18F]AlF-RESCA-HER2-BCH and [18F]AlF-NOTA-HER2-BCH in mice and breast cancer patients","volume":"50","author":"Liu","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024111408000982000_jnumed.124.268751v1.28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-med-071322-065903","article-title":"Leveraging TROP2 antibody-drug conjugates in solid tumors","volume":"75","author":"Nelson","year":"2024","journal-title":"Annu Rev Med."},{"key":"2024111408000982000_jnumed.124.268751v1.29","doi-asserted-by":"crossref","first-page":"CT181","DOI":"10.1158\/1538-7445.AM2023-CT181","article-title":"A first-in-human (FIH) phase 1 study of SHR-A1921, a TROP-2 targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors [abstract]","volume":"83(suppl)","author":"Wang","year":"2023","journal-title":"Cancer Res."},{"key":"2024111408000982000_jnumed.124.268751v1.30","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.7150\/thno.98178","article-title":"Trop2-targeted therapies in solid tumors: advances and future directions","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics."},{"key":"2024111408000982000_jnumed.124.268751v1.31","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/S1470-2045(19)30821-6","article-title":"Radiotheranostics: a roadmap for future development","volume":"21","author":"Herrmann","year":"2020","journal-title":"Lancet Oncol."},{"key":"2024111408000982000_jnumed.124.268751v1.32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41571-022-00652-y","article-title":"Radiotheranostics in oncology: current challenges and emerging opportunities","volume":"19","author":"Bodei","year":"2022","journal-title":"Nat Rev Clin Oncol."},{"key":"2024111408000982000_jnumed.124.268751v1.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05218-1"},{"key":"2024111408000982000_jnumed.124.268751v1.34","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3925"},{"key":"2024111408000982000_jnumed.124.268751v1.35","doi-asserted-by":"publisher","DOI":"10.18632\/genesandcancer.40"},{"key":"2024111408000982000_jnumed.124.268751v1.36","doi-asserted-by":"publisher","DOI":"10.1369\/0022155411410430"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.268751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T16:00:22Z","timestamp":1731600022000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.268751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":36,"alternative-id":["10.2967\/jnumed.124.268751"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.268751","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}